nivolumab
bms
['nivolumab', 'check,mate,274', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivo']
the #oncoalerttoptweet day 2 #gu23
tweet checkmate 274 trial update at median follow-up 36.1 months. median dfs 22.0 months nivolumab vs 10.9 months w/placebo patients w/ pd-l1 1%, nivolumab median dfs 52.6 mo vs. 8.4 mo w/placebo best 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨